首页   >  
Cell Cycle/DNA Damage
  >  
DNA/RNA Synthesis

所有产品分类

所有产品

信号通路

研究领域

天然产物

抗体

多肽

催化剂

杂质对照品

医药中间体

基础原料

DNA/RNA Synthesis

结构式 货号 产品名称 CAS号
Ancitabine hydrochloride 结构式
 BCP12373 盐酸环胞苷 10212-25-6
Ancitabine hydrochloride is a hydrochloride salt resulting from the reaction of equimolar amounts of ancitabine and hydrogen chloride. It has a role as an antimetabolite and an antineoplastic agent. It contains an ancitabine(1+).
DATP-N3 结构式
 BCP46395 DATP-N3 1048021-78-8
DATP is a purine nucleoside triphosphate used in the synthesis of DNA by being incorporated into DNA.
DCTP-N3 结构式
 BCP49643 DCTP-N3 1048021-94-8
DCTP is a nucleoside triphosphate that can be used for DNA synthesis. Deoxycytidine triphosphate has many applications, such as real-time PCR, cDNA synthesis, and DNA sequencing.
6-Thio-2'-Deoxyguanosine 结构式
 BCP16135 6-巯基-2'-脱氧鸟苷 789-61-7
6-Thio-2'-Deoxyguanosine is a nucleoside analog and telomerase substrate.
Bersiporocin dihydrochloride 结构式
 BCP49201 Bersiporocin dihydrochloride 2241808-53-5
Bersiporocin is a prolyl-tRNA synthetase inhibitor.
DDD85646 结构式
 BCP28646 DDD85646 1215010-55-1
DDD85646 is a potent inhibitor of trypanosoma brucei N-myristoyltransferase (TbNMT IC50=2 nm; hNMTIC50=4 nm). The enzyme N-myristoyltransferase (NMT) is a potential drug target for human African trypanosomiasis.
AVN-944 结构式
 BCP23877 AVN-944 297730-17-7
AVN944 is a biotech drug that demonstrated a statistically meaningful impact on IMPDH and other proteins that are critical to activities in cancer cells, including nucleotide biosynthesis, energy and metabolism, DNA replication, apoptosis and cell cycle control. AVN944 has been associated with cancer cell death in clinical trials. It is being investigated for the treatment of patients with advanced hematologic malignancies.
Zinostatin 结构式
 BCP48970 新制癌菌素 9014-02-2
Zinostatin is a cytotoxic enediyne that alkylates DNA and RNA like mitomycin does. It has antineoplastic and antibiotic properties. It is isolated from the bacterium Streptomyces carzinostaticus. It may be active against hepatocellular carcinoma.
Bractoppin 结构式
 BCP48934 Bractoppin 2290527-07-8
Bractoppin is a potent and selective drug-like inhibitor of phosphopeptide recognition by the human BRCA1 tandem(t) BRCT domain (binding IC50: 74 nM). Bractoppin diminishes BRCA1 recruitment to DNA breaks, in turn suppressing damage-induced G2 arrest and assembly of the recombinase, RAD51. Bractoppin preferentially inhibits BRCA1 tBRCT-dependent steps in the DNA damage response.
DDTT 结构式
 BCP25080 DDTT 1192027-04-5
DDTT as a novel efficient sulfur transfer reagents suitable for DNA and RNA synthesis.
123下一页末页共 148 条记录 1 / 15 页 
2853530910